Revenues for the top 7 Pharma companies continue to rise, except MSD, which saw a 2% dip in Q2 sales

First quarter (Q1), and Second quarter (Q2) revenue (in USD) for seven pharmaceutical companies for the years 2024 and 2025.

(Please use a modern browser to see the interactive version of this visualization)

Note: For Roche, revenues in CHF were converted into USD using the average conversion rates for 2024 (1 CHF = 1.1362 USD) and 2025 (1 CHF = 1.1846 USD).

Chart: © Phalguni Deswal, Drug and Device World (www.druganddeviceworld.com)Source: Data from the respective companies financial disclosuresDownload imageCreated with Datawrapper